autologous CD34+ cell therapy (Clinical Technology Centre (Ireland))

N/A

Report date: 2025/01/26 19:35:49

Base Information

Drug Nameautologous CD34+ cell therapy (Clinical Technology Centre (Ireland))
Drug Alias Nameglucosylceramidase beta cell therapy (Clinical Technology Centre)lentiviral vector based autologous CD34+ cell therapy (Clinical Technology Centre (Ireland))
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionGlucosylceramidase modulators
TargetsGlucosylceramidase
Therapy Area/IndicationsGaucher Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesClinical Technology Centre (Ireland) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesClinical Technology Centre (Ireland) Ltd
Inactive CompaniesN/A
Active IndicationsGaucher Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A